Thilo Kaltenbach
Dr. Thilo Kaltenbach is a Senior Partner in Roland Berger’s Pharma & Healthcare practice in Munich. He advises healthcare organizations, Pharmaceuticals and Medical Technology companies as well as financial investors worldwide on Healthcare related topics.
His primary focus is to help organizations on transformational pathways. These might be initiated by innovations, technological advancement, ownership changes, financing related issues, as well as upcoming crisis situations.
Thilo is Co-Author of the Future of Health series, a Roland Berger thought leadership publication dealing with transformative developments in healthcare, as well as of the global Pharma and the global Medtech study.
In addition, he is engaged in many transformation projects for healthcare organizations worldwide.
Thilo is a registered pharmacist and holds a PhD in Pharmaceutical Chemistry and a degree in Business Administration.
Consulting means to be there for my clients, and to help them navigate with clarity through complex transformations
Long and healthy life
Podcast, April 9, 2025
ESG in MedTech
Podcast, March 26, 2025
Ensuring future drug availability
Podcast, March 12, 2025
Global MedTech: Balancing innovation and operational efficiency
STUDY, February 20, 2025
Future of health 6 - The AI (r)evolution in health
Study, November 20, 2024
Operational excellence benchmarking: Shaping the future of MedTech
Article, November 13, 2024
Global Pharma Study 2024 – a new age of performance programs
Study, October 22, 2024
Why AI is a game changer for the pharmaceutical industry
Article, October 8, 2024
Unlocking value in the CDMOs market
Article, July 3, 2024
Designing your global manufacturing network
Article, March 15, 2024
Global MedTech 2023 – How companies stem the tide
STUDY, November 16, 2023
Cell and gene therapies: Strategies for commercial success
Article, November 14, 2023
Future of health 5 - A long and healthy life
Study, November 8, 2023
Available in DE
Rheinland-Pfalz as a biotech location: Potential for a leading position
Article, July 21, 2023
Robotics in surgery
STUDY, June 13, 2023
Beyond the numbers: Key characteristics of successful pharma companies
Study, May 24, 2023
M&A opportunities in biotechnology
Article, November 7, 2022
Can the MedTech sector keep outperforming?
Study, October 27, 2022
Future of health 4 – The patients of tomorrow
Focus, September 28, 2022
Mastering supply chain crises in the pharmaceutical industry
Article, July 11, 2022
MedTech@Hospital 2021
Flyer, November 29, 2021
Future of health 3 - How the phygital model is going to transform healthcare
Study, September 24, 2021
Cell and gene therapies: Pharma's next big wave
Study, May 5, 2021
Growth ahead: German hospitals need MedTech companies more than ever
Study, November 20, 2020
Future of health 2 – The rise of healthcare platforms
Study, September 30, 2020
The next revolution in chemicals
White paper, September 7, 2020
Production efficiency in pharmaceutical manufacturing
White paper, April 21, 2020
Performance Improvement: How pharma businesses can safeguard viable margins
White paper, January 29, 2020
Future of health - Digitalization in the healthcare sector
Study, October 22, 2019
Digital therapeutics: An exciting innovation, but not without challenges
Article, May 15, 2019
Regenerative medicine
Study, October 2, 2017
Digital and disrupted: All change for healthcare (Switzerland)
Think:Act, December 19, 2016
Digital and disrupted: All change for healthcare
Think:Act, September 28, 2016
Business models for digital health start-ups
Point of view, July 15, 2016